Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Cleaning and Decontamination of Cell Culture Areas – V 2.0

Posted on By


Biosimilars: SOP for Cleaning and Decontamination of Cell Culture Areas – V 2.0


Standard Operating Procedure for Cleaning and Decontamination of Cell Culture Areas in Biosimilar Labs

Department Biosimilars
SOP No. SOP/BS/047/2025
Supersedes SOP/BS/047/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the procedure for routine cleaning and decontamination of cell culture laboratories used in biosimilar development to maintain aseptic processing conditions and prevent microbial or cross-contamination.

2. Scope

This SOP is applicable to all ISO-classified biosimilar laboratories, clean rooms, and associated areas involved in mammalian cell culture processes.

3. Responsibilities

  • Housekeeping Staff: Perform scheduled cleaning as per instructions using approved disinfectants.
  • Lab Technicians: Ensure work surfaces and biosafety cabinets are disinfected before and after use.
  • QA Team: Verify cleaning records and conduct cleanliness inspections.

4. Accountability

The Head of Biosimilar Operations is accountable for ensuring adherence to this cleaning SOP, and maintaining contamination-free culture environments.

5. Procedure

5.1 Cleaning Frequency and Schedule

  1. Daily:
    • Floor mopping with disinfectant
    • Wipe workbenches, door handles, switches
  2. Weekly:
    • Wall and ceiling wipe-down
    • Clean drains and air vent covers
  3. Monthly:
    • Disinfection behind equipment and storage cabinets

5.2 Cleaning Agents and Disinfectants

  1. Use approved disinfectants such as:
    • 70% Isopropyl Alcohol (IPA)
    • 1% Sodium Hypochlorite
    • 0.5% Hydrogen Peroxide
  2. Rotate disinfectants monthly to avoid resistance.
  3. Maintain Disinfectant Preparation and Usage Log (Annexure-1).

5.3 Cleaning Technique

  1. Follow unidirectional wiping — top to bottom, clean to dirty.
  2. Use sterile lint-free wipes; discard after single use.
  3. For floors, use color-coded mop heads specific to area classification.
  4. Do not re-use contaminated wipes or mops.

5.4 Biosafety Cabinet Decontamination

  1. Before each use:
    • Wipe all surfaces with 70% IPA
    • Allow 10-minute air purge after blower startup
  2. Weekly:
    • Clean base tray, sash, and side walls
    • Record in BSC Cleaning Log (Annexure-2)

5.5 Fumigation and Terminal Decontamination

  1. Performed quarterly or during contamination incidents.
  2. Use fogging with validated agents (e.g., 6% hydrogen peroxide).
  3. Document in the Terminal Decontamination Log (Annexure-3).

5.6 Waste Handling During Cleaning

  1. Collect used wipes, PPE, and disposables in biohazard bags.
  2. Dispose as per biohazard SOP for contaminated materials.
  3. Label and segregate infectious waste from general lab trash.

5.7 Documentation

  1. Fill cleaning records immediately after completion.
  2. Records to be signed by cleaning personnel and verified by lab-in-charge or QA.

6. Abbreviations

  • IPA: Isopropyl Alcohol
  • BSC: Biosafety Cabinet
  • QA: Quality Assurance

7. Documents

  1. Disinfectant Preparation and Usage Log (Annexure-1)
  2. BSC Cleaning Log (Annexure-2)
  3. Terminal Decontamination Log (Annexure-3)

8. References

  • WHO TRS 961 – GMP for Biological Products
  • Schedule M – Good Manufacturing Practices (India)
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Disinfectant Preparation and Usage Log

Date Disinfectant Concentration Prepared By Used In
03/05/2025 Hydrogen Peroxide 0.5% Ajay Verma CLD Room

Annexure-2: BSC Cleaning Log

Date Cabinet ID Surface Cleaned Cleaned By Verified By
04/05/2025 BSC-102 Interior, Tray Sunita Reddy Vinay Pawar

Annexure-3: Terminal Decontamination Log

Date Room ID Agent Used Method Performed By
01/04/2025 CLD-1 6% H₂O₂ Fogging QA Team

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added fumigation and wall cleaning guidance Routine SOP Upgrade
See also  Biosimilars: SOP for Audit Readiness of CLD Documentation - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: BA-BE Studies: SOP for Handling Cold Chain Breaches During Sample Storage – V 2.0
Next Post: API Manufacturing: SOP for Cross-Verification of IPC Data by QA – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version